期刊文献+

苯磺酸氨氯地平合并卡托普利治疗老年高血压病152例疗效观察 被引量:3

Amlodipine combined with Captopril treatment of elderly patients with hypertension Efficacy of 76cases
下载PDF
导出
摘要 目的:观察苯磺酸氨氯地平合并卡托普利治疗老年高血压病临床疗效。方法:152例老年性高血压患者根据性别随机分成两组,A组:苯磺酸氨氯地平合并卡托普利老年患者76例;B组:单用卡托普利老年患者76例。观察降压效果、心率、血糖、血脂、肝功能的影响。结果:A组显效56例,有效15例,无效5例,总有效率93.42%。B组显效49例,有效15例,无效12例,总有效率84.21%。两组比较有差异性。结果:苯磺酸氨氯地平合并卡托普利对老年性高血压降压效果明显,同时对心率、血糖、血脂、肝功能无明显改变,是治疗老年性高血压适宜用药。 Objeetive:To observe the combined amlodipine besylate captopril treatment of elderly hypertension clinical efficacy. Methods: 152 patients with senile hypertension were randomly divided into two groups according to gender, A Group: Amlodipine combined with captopril in elderly patients with 76 eases; B Group: Single with captopril in elderly patients 76 Li. Observed reduction in blood pressure, heart rate, blood sugar, blood lipids, liver function. Results: A group of 56 cases markedly effective in 15 cases, ineffective in 5 cases. The total effective rate 93.42%. B group of 49 cases markedly effective in 15 cases, ineffective in 12 cases, total effective rate was 84.21%. There are differences in the two groups, two groups of elderly hypertensive heart rate after ueatment, blood glucose, blood lipids, liver function. Cortelusions: Amlodipine combined antihypertensive effect of eaptopril in elderly hypertensive effect significantly, while heart rate, blood sugar, blood lipids, liver function and no signifieant change; it is suitable for treatment of elderly hypertensive medication.
作者 蒋勇
出处 《北方药学》 2012年第1期17-18,共2页 Journal of North Pharmacy
关键词 老年性高血压 苯磺酸氨氯地平 卡托普利 Senile hypertension Amlodipine besylate Captopril
  • 相关文献

参考文献2

二级参考文献18

  • 1徐济民,黄震华,郑慧君,林淑英,李进禧,朱亮,陆琛.硝酸异山梨酯静脉内输注治疗冠心病心绞痛102例[J].新药与临床,1997,16(1):10-12. 被引量:17
  • 2郭翼珍,新药与临床,1997年,16卷,153页
  • 3徐济民,新药与临床,1997年,16卷,10页
  • 4徐济民,临床实用新药手册,1996年,257页
  • 5Pitt B,Segal R.Martinez FA,et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).Lancet, 1997,349:747-752.
  • 6Pitt B,Poole-Wilson PA,Segal R,et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.Lancet, 2000,355:1582-1587.
  • 7Daholof B,Devereux RB,Kjeldsen SE,et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.Lancet,2002,359:995-1003.
  • 8Lewis EJ,Hunsicker LG,Clarke WR,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.N Engl J Med, 2001,345:851-860.
  • 9Circulation, 2002;106:672.
  • 10Parving HH,Lehnert H,Brochner-Mortensen J,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.N Engl J Med, 2001,345:870-878.

共引文献94

同被引文献34

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部